Filters
Other countries
Results: 1 to 13 of 13
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
CCDC115 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 210 | 134 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 253 | 189 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
CCDC115 - Congenital disorder of glycosylation type IIo Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 1 | 1 |
|
Congenital Disorders of Glycosylation (CDG) Panel PreventionGenetics, part of Exact Sciences United States | 56 | 54 |
|
Invitae Copper Metabolism Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 15 | 10 |
|
Invitae Congenital Disorders of Glycosylation Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 203 | 152 |
|
Congenital disorder of glycosylation, type 2: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 20 | 20 |
|
Congenital disorders of glycosylation, type II: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 17 | 17 |
|
Results: 1 to 13 of 13
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.